BIO Expresses Disappointment with House Vote on Patent Reform.Notes Strong, Bipartisan Opposition in the House, Will Continue to Work with the Senate to Achieve Meaningful Improvements to the U.S. Patent System WASHINGTON -- The following statement was issued by Jim Greenwood, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
"BIO appreciates the continued efforts by the House to improve the Patent Reform Act, but unfortunately cannot support the legislation passed today as it threatens continued biotechnological innovation. We welcome improvements to the U.S. patent system, particularly those that increase patent quality, increase public participation, and provide additional resources to the Patent and Trademark Office (PTO PTO abbr. 1. Parent Teacher Organization 2. or p.t.o. please turn over 3. power takeoff PTO or pto please turn over Noun 1. ). However, the legislation that passed the House today and the legislation currently pending in the Senate do more harm than good to our nation's patent system. "While we are disappointed that the legislation passed the House, we were heartened that it did so narrowly and that there was strong bipartisan opposition to the bill. This opposition demonstrates the serious concern of varied stakeholders -- across many industries, research institutions and other interests -- with the bill and the need for a more consensus-oriented approach to patent law reform. "We look forward to working with the Senate to improve upon this legislation, particularly with respect to provisions relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc damages, inequitable conduct In United States patent law, patent holders must go to the federal courts to enforce their patent rights. Even if the patent is valid and infringed, these courts may exercise their equitable discretion not to enforce the patent if the patentee has engaged in inequitable conduct. reform, post-grant review proceedings and PTO rulemaking authority." About BIO BIO represents more than 1,100 biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the global event for biotechnology. www.bio.org
Upcoming BIO Events
-- BIO Mid-America VentureForum 2007
Sep. 24-26, 2007
Milwaukee, WI
-- BIO InvestorForum 2007
October 9-11, 2007
San Francisco, CA
-- BIO International Convention
June 17-20, 2008
San Diego, CA
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion